Insights into the inhibitory activities of neolignans and diarylnonanoid derivatives from nutmeg (Myristica fragrans Houtt.) seeds on soluble epoxide hydrolase using in vitro and in silico approaches

References

• Atone J, Wagner K, Hashimoto K, Hammock BD. Cytochrome P450 derived epoxidized fatty acids as a therapeutic tool against neuroinflammatory diseases. Prostaglandins Other Lipid Mediat. 2020;147:106385.
   PubMed Web of Science ®Google Scholar
• Lukin A, Kramer J, Hartmann M, Weizel L, Hernandez-Olmos V, Falahati K, Burghardt I, Kalinchenkova N, Bagnyukova D, Zhurilo N, et al. Discovery of polar spirocyclic orally bioavailable urea inhibitors of soluble epoxide hydrolase. Bioorg Chem. 2018;80:655–667.
   PubMed Web of Science ®Google Scholar
• Spector AA, Fang X, Snyder GD, Weintraub NL. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res. 2004;43(1):55–90.
   PubMed Web of Science ®Google Scholar
• Fretland AJ, Omiecinski CJ. Epoxide hydrolases: biochemistry and molecular biology. Chem Biol Interact. 2000;129(1–2):41–59.
   PubMed Web of Science ®Google Scholar
• Huang H, Weng J, Wang M-H. EETs/sEH in diabetes and obesity-induced cardiovascular diseases. Prostaglandins Other Lipid Mediat. 2016;125:80–89.
   PubMed Web of Science ®Google Scholar
• Briggs WH, Xiao H, Parkin KL, Shen C, Goldman IL. Differential inhibition of human platelet aggregation by selected Allium thiosulfinates. J Agric Food Chem. 2000;48(11):5731–5735.
   PubMed Web of Science ®Google Scholar
• Halade GV, Lee DH. Inflammation and resolution signaling in cardiac repair and heart failure. eBioMedicine. 2022;79:103992.
   PubMed Web of Science ®Google Scholar
• Gur Maz T, Koc B, Jordan PM, İbiş K, Çalışkan B, Werz O, Banoglu E. Benzoxazolone-5-urea derivatives as human soluble epoxide hydrolase (sEH) inhibitors. ACS Omega. 2023;8(2):2445–2454.
   PubMedGoogle Scholar
• Imig JD, Carpenter MA, Shaw S. The soluble epoxide hydrolase inhibitor AR9281 decreases blood pressure, ameliorates renal injury and improves vascular function in hypertension. Pharmaceuticals). 2009;2(3):217–227.
   Google Scholar
• Kim JH, Park JS, Lee YJ, Choi S, Kim YH, Yang SY. Inhibition of soluble epoxide hydrolase by phytochemical constituents of the root bark of Ulmus davidiana var. japonica. J Enzyme Inhib Med Chem. 2021;36(1):1049–1055.
   PubMed Web of Science ®Google Scholar
• Phong NV, Zhao Y, Min BS, Yang SY, Kim JA. Inhibitory activity of bioactive phloroglucinols from the rhizomes of Dryopteris crassirhizoma on Escherichia coli β-glucuronidase: kinetic analysis and molecular docking studies. Metabolites. 2022;12(10):938.
   PubMed Web of Science ®Google Scholar
• Ha MT, Vu NK, Tran TH, Kim JA, Woo MH, Min BS. Phytochemical and pharmacological properties of Myristica fragrans Houtt.: an updated review. Arch Pharm Res. 2020;43(11):1067–1092.
   PubMed Web of Science ®Google Scholar
• Lee C-J, Huang C-W, Chen L-G, Wang C-C. (+)-Erythro-Δ8′-7S,8R-dihydroxy-3,3′,5′-trimethoxy-8-O-4′-neolignan, an anti-acne component in degreasing Myristica fragrans Houtt. Molecules. 2020;25(19):4563.
   PubMed Web of Science ®Google Scholar
• Barceloux DG. Nutmeg (Myristica fragrans Houtt.). Dis Mon. 2009;55(6):373–379.
   PubMed Web of Science ®Google Scholar
• Cao G-Y, Xu W, Yang X-W, Gonzalez FJ, Li F. New neolignans from the seeds of Myristica fragrans that inhibit nitric oxide production. Food Chem. 2015;173(:231–237.
   PubMed Web of Science ®Google Scholar
• Wang CY, Lee S, Jang H-J, Su XD, Wang H-S, Kim YH, Yang SY. Inhibition potential of phenolic constituents from the aerial parts of Tetrastigma hemsleyanum against soluble epoxide hydrolase and nitric oxide synthase. J Enzyme Inhib Med Chem. 2019;34(1):753–760.
   PubMed Web of Science ®Google Scholar
• Jiang J-x, Guan Y, Shen H-j, Jia Y-l, Shen J, Zhang L-h, Liu Q, Zhu Y-l, Xie Q-m. Inhibition of soluble epoxide hydrolase attenuates airway remodeling in a chronic asthma model. Eur J Pharmacol. 2020;868:172874.
   PubMed Web of Science ®Google Scholar
• Tanaka D, Tsuda Y, Shiyama T, Nishimura T, Chiyo N, Tominaga Y, Sawada N, Mimoto T, Kusunose N. A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors. J Med Chem. 2011;54(3):851–857.
   PubMed Web of Science ®Google Scholar
• Eawsakul K, Ongtanasup T, Ngamdokmai N, Bunluepuech K. Alpha-glucosidase inhibitory activities of astilbin contained in Bauhinia strychnifolia Craib. stems: an investigation by in silico and in vitro studies. BMC Complement Med Ther. 2023;23(1):25.
   PubMedGoogle Scholar
• Ongtanasup T, Prommee N, Jampa O, Limcharoen T, Wanmasae S, Nissapatorn V, Paul AK, Pereira ML, Wilairatana P, Nasongkla N, et al. The cholesterol-modulating effect of the new herbal medicinal recipe from yellow vine (Coscinium fenestratum (Goetgh.)), ginger (Zingiber officinale Roscoe.), and safflower (Carthamus tinctorius L.) on suppressing PCSK9 expression to upregulate LDLR expression in HepG2 cells. Plants. 2022;11(14):1835.
   Google Scholar
• Nasongkla N, Tuchinda P, Munyoo B, Eawsakul K. Preparation and characterization of MUC-30-loaded polymeric micelles against MCF-7 cell lines using molecular docking methods and in vitro study. Evid Based Complement Alternat Med. 2021;2021:5597681–5597689.
   PubMed Web of Science ®Google Scholar
• Phong NV, Anh DTN, Chae HY, Yang SY, Kwon MJ, Min BS, Kim JA. Anti-inflammatory activity and cytotoxicity against ovarian cancer cell lines by amide alkaloids and piperic esters isolated from Piper longum fruits: In vitro assessments and molecular docking simulation. Bioorg Chem. 2022;128:106072.
   PubMed Web of Science ®Google Scholar
• Khoa NM, Phong NV, Yang SY, Min BS, Kim JA. Spectroscopic analysis, kinetic mechanism, computational docking, and molecular dynamics of active metabolites from the aerial parts of Astragalus membranaceus Bunge as tyrosinase inhibitors. Bioorg Chem. 2023;134:106464.
   PubMed Web of Science ®Google Scholar
• Li F, Yang X-W. Biotransformation of myrislignan by rat liver microsomes in vitro. Phytochemistry. 2008;69(3):765–771.
   PubMed Web of Science ®Google Scholar
• Duan L, Tao H-W, Hao X, Gu Q-Q, Zhu W-M. Cytotoxic and antioxidative phenolic compounds from the traditional Chinese medicinal plant, Myristica fragrans. Planta Med. 2009;75(11):1241–1245.
   PubMed Web of Science ®Google Scholar
• Zacchino SA, Badano H. Enantioselective synthesis and absolute configuration assignment of erythro(3,4,5-trimethoxy-7-hydroxy-1′-allyl-2′, 6′-dimethoxy)-8.0.4′-neolignan, isolated from mace (Myristica fragrans). J Nat Prod. 1988;51(6):1261–1265.
   Web of Science ®Google Scholar
• Rye CE, Barker D. Asymmetric synthesis and anti-protozoal activity of the 8,4′-oxyneolignans virolin, surinamensin and analogues. Eur J Med Chem. 2013;60:240–248.
   PubMed Web of Science ®Google Scholar
• Hattori M, Hada S, Shu Y-Z, Kakiuchi N, Namba T. New acyclic bis-phenylpropanoids from the aril of Myristica fragrans. Chem Pharm Bull. 1987;35(2):668–674.
   Web of Science ®Google Scholar
• Francis SK, James B, Varughese S, Nair MS. Phytochemical investigation on Myristica fragrans stem bark. Nat Prod Res. 2019;33(8):1204–1208.
   PubMed Web of Science ®Google Scholar
• Morikawa T, Hachiman I, Matsuo K, Nishida E, Ninomiya K, Hayakawa T, Yoshie O, Muraoka O, Nakayama T. Neolignans from the arils of Myristica fragrans as potent antagonists of CC chemokine receptor 3. J Nat Prod. 2016;79(8):2005–2013.
   PubMed Web of Science ®Google Scholar
• Olajide OA, Ajayi FF, Ekhelar AI, Awe SO, Makinde JM, Alada ARA. Biological effects of Myristica fragrans (nutmeg) extract. Phytother Res. 1999;13(4):344–345.
   PubMed Web of Science ®Google Scholar
• Kasahara H, Miyazawa M, Kameoka H. Biotransformation of an acyclic neolignan in rats. Phytochemistry. 1995;38(2):343–346.
   PubMed Web of Science ®Google Scholar
• Kundu K, Nayak SK. Total syntheses of malabaricones B and C via a cross-metathesis strategy. J Nat Prod. 2017;80(6):1776–1782.
   PubMed Web of Science ®Google Scholar
• Besombes S, Robert D, Utille J-P, Taravel FR, Mazeau K. Molecular modeling of syringyl and p-hydroxyphenyl β-O-4 dimers. Comparative study of the computed and experimental conformational properties of lignin β-O-4 model compounds. J Agric Food Chem. 2003;51(1):34–42.
   PubMed Web of Science ®Google Scholar
• Arnoldi A, Merlini L. Asymmetric synthesis of 3-methyl-2-phenyl-1,4-benzodioxanes. Absolute configuration of the neolignans eusiderin and eusiderin C and D. J Chem Soc, Perkin Trans 1. 1985;17:2555–2557.
   Google Scholar
• Hada S, Hattori M, Tezuka Y, Kikuchi T, Namba T. New neolignans and lignans from the aril of Myristica fragrans. Phytochemistry. 1988;27(2):563–568.
   Web of Science ®Google Scholar
• Gao X, Shen Y, Yang L, Shu L, Li G, Hu Q-F. 8-O-4′-neolignans from flower buds of Magnolia fargesii and their biological activities. J Braz Chem Soc. 2012;23(7):1274–1279.
   Web of Science ®Google Scholar
• Morikawa T, Hachiman I, Ninomiya K, Hata H, Sugawara K, Muraoka O, Matsuda H. Degranulation inhibitors from the arils of Myristica fragrans in antigen-stimulated rat basophilic leukemia cells. J Nat Med. 2018;72(2):464–473.
   PubMed Web of Science ®Google Scholar
• Di Bari L, Pescitelli G, Pratelli C, Pini D, Salvadori P. Determination of absolute configuration of acyclic 1,2-diols with Mo2(OAc)4. 1. Snatzke’s method revisited. J Org Chem. 2001;66(14):4819–4825.
   PubMed Web of Science ®Google Scholar
• Huong PTM, Phong NV, Huong NT, Trang DT, Thao DT, Cuong NX, Nam NH, Van Thanh N. Aplydactylonins A-C, three new sesquiterpenes from the Vietnamese sea hare Aplysia dactylomela and their cytotoxicity. J Nat Med. 2022;76(1):210–219.
   PubMed Web of Science ®Google Scholar
• Whiteley CG. Enzyme kinetics: partial and complete non-competitive inhibition. Biochem Educ. 1999;27(1):15–18.
   Google Scholar
• Dixon M. The determination of enzyme inhibitor constants. Biochem J. 1953;55(1):170–171.
   PubMed Web of Science ®Google Scholar
• Bzówka M, Mitusińska K, Hopko K, Góra A. Computational insights into the known inhibitors of human soluble epoxide hydrolase. Drug Discov Today. 2021;26(8):1914–1921.
   PubMed Web of Science ®Google Scholar
• Zhao W-Y, Yan J-J, Zhang M, Wang C, Feng L, Lv X, Huo X-K, Sun C-P, Chen L-X, Ma X-C. Natural soluble epoxide hydrolase inhibitors from Inula britanica and their potential interactions with soluble epoxide hydrolase: insight from inhibition kinetics and molecular dynamics. Chem Biol Interact. 2021;345:109571.
   PubMed Web of Science ®Google Scholar
• Gomez GA, Morisseau C, Hammock BD, Christianson DW. Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis. Biochemistry. 2004;43(16):4716–4723.
   PubMed Web of Science ®Google Scholar
• Qiu Q, Abis G, Mattingly-Peck F, Lynham S, Fraternali F, Conte MR. Allosteric regulation of the soluble epoxide hydrolase by nitro fatty acids: a combined experimental and computational approach. J Mol Biol. 2022;434(17):167600.
   PubMed Web of Science ®Google Scholar
• Jo AR, Kim JH, Yan X-T, Yang SY, Kim YH. Soluble epoxide hydrolase inhibitory components from Rheum undulatum and in silico approach. J Enzyme Inhib Med Chem. 2016;31(sup2):70–78.
   PubMed Web of Science ®Google Scholar
• Phong NV, Yang SY, Min BS, Kim JA. Insights into the inhibitory activity and mechanism of action of flavonoids from the stems and branches of Acer mono Maxim. against α-glucosidase via kinetic analysis, molecular docking, and molecular dynamics simulations. J Mol Struct. 2023;1282:135188.
   Web of Science ®Google Scholar
• Ashiru MA, Ogunyemi SO, Temionu OR, Ajibare AC, Cicero-Mfon NC, Ihekuna OA, Jagun MO, Abdulmumin L, Adisa QK, Asibor YE, et al. Identification of EGFR inhibitors as potential agents for cancer therapy: pharmacophore-based modeling, molecular docking, and molecular dynamics investigations. J Mol Model. 2023;29(5):128.
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7(1):42717.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 1997;23(1–3):3–25.
   Web of Science ®Google Scholar
• Bickerton GR, Paolini GV, Besnard J, Muresan S, Hopkins AL. Quantifying the chemical beauty of drugs. Nat Chem. 2012;4(2):90–98.
   PubMed Web of Science ®Google Scholar
• Ongtanasup T, Wanmasae S, Srisang S, Manaspon C, Net-Anong S, Eawsakul K. In silico investigation of ACE2 and the main protease of SARS-CoV-2 with phytochemicals from Myristica fragrans (Houtt.) for the discovery of a novel COVID-19 drug. Saudi J Biol Sci. 2022;29(9):103389.
   PubMed Web of Science ®Google Scholar
• Ongtanasup T, Mazumder A, Dwivedi A, Eawsakul K. Homology modeling, molecular docking, molecular dynamic simulation, and drug-likeness of the modified alpha-mangostin against the β-tubulin protein of Acanthamoeba keratitis. Molecules. 2022;27(19):6338.
   PubMed Web of Science ®Google Scholar
• Meng F, Xi Y, Huang J, Ayers PW. A curated diverse molecular database of blood-brain barrier permeability with chemical descriptors. Sci Data. 2021;8(1):289.
   PubMed Web of Science ®Google Scholar